Pace Of Drug Price Activity In Congress A Reason For Optimism
Mar 5, 2019
Three More Hearings Will Keep Attention On The Impact Of Big Pharma’s… Read More
© 2024 CSRXP- All Rights Reserved
Updates
Headlines: Big Pharma Reboots Tired Tactics During Hill Grilling
Feb 28, 2019
Testimony from Seven Drug Makers Showcases Continued Unwillingness to Take… Read More
They Said It: Senators Slam Big Pharma CEOs For Price Gouging, Anti-Competitive Tactics
Feb 27, 2019
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on… Read More
CSRxP Statement on Testimony of Seven Pharmaceutical Executives Before Senate Finance Committee
Feb 26, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released… Read More
“DOSE OF REALITY” Recap
Feb 26, 2019
Big Pharma’s True Track Record Is A Hard Pill To Swallow Looking back at Big… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VII
Feb 25, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
Big Pharma must be held accountable for insulin price crisis
Feb 23, 2019
By Sarah Gleich Saturday, Feb. 23, 2019 I have had diabetes since I was 5… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VI
Feb 22, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part V
Feb 21, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part IV
Feb 20, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part III
Feb 19, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part II
Feb 18, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More